Product Spotlight: Aveeno Calm + Restore Redness Relief Foaming Cleanser

Screenshot 20250331 071130 Gallery

Globally, the rosacea treatment market, including antibiotics, alpha agonists, retinoids and corticosteroids, was estimated at US $2.08 billion in 2024, and is projected to rise at a 7.1% CAGR (2025 to 2030), per Grand View Research. The source cites drivers including urbanization, environmental changes, lifestyle shifts and the rapidly growing aging population, since rosacea is more common in middle-aged and older adults. Rosacea can cause facial redness, pimples and visible blood vessels, which can have significant cosmetic and psychological effects, Grand View Research explains. The firm adds that combinations of therapies, such as antibiotics with topical treatments, or light therapy with oral medications, have become more common. The Aveeno brand Calm + Restore Redness Relief Foaming Cleanser, featuring feverfew, provides a topical product example.

Log in to view the full article
More in Skin Care